2m 2m 2m 2m 2m 2m 2m
OLEMA PHARMA (OLMA)
NASDAQ
$7.07+$0.05 (+0.77%)
Price as of Oct 22, 2026 7:30 PM EDT- $616.9MMarket Cap
- -13.23%1-Year Change
- BiotechnologyIndustry
OLEMA PHARMA (OLMA)
$7.07+$0.05 (+0.77%)
OLMA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.02 | ||
Change | -$0.03 (-0.43%) | ||
Open | $6.96 | ||
High | $7.10 | ||
Low | $6.83 | ||
Previous Close | $7.05 | ||
Volume | 1,064,868 | ||
30-Day Average Volume | 1,269,638 | ||
1-Week Change | 2.18% | ||
1-Month Change | -27.18% | ||
1-Year Change | -13.23% | ||
3-Year Change | -33.71% | ||
5-Year Change | -74.73% | ||
Fundamentals | |||
Shares Outstanding | 87.5M | ||
Total Assets | $486.6M | ||
Market Cap | $616.9M | ||
Enterprise Value | $571.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$63.2M | ||
Free Cash Flow | -$45.9M | ||
EBIT | -$63.2M | ||
EBITDA | -$63.1M | ||
Net Working Capital | $416.9M | ||
EPS | -$0.61 | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -12 | ||
PEG | 1 | ||
Price/Free Cash Flow | -13 | ||
Price/Operating Cash Flow | -13 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue